No Data
No Data
Morgan Stanley Maintains CRISPR Therapeutics(CRSP.US) With Sell Rating, Maintains Target Price $45
A Quick Look at Today's Ratings for CRISPR Therapeutics(CRSP.US), With a Forecast Between $30 to $95
CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Cathie Wood's ARK Investment Bought 409.5K Shares of Crispr Therapeutics Today
Trending Industry Today: Coinbase Leads Gains In ARK Portfolio Stocks
No Data
No Data
104013278 : while both counter are raise significantly
ZnWC : Ark Invest buy and sell Tesla stock to adjust the portfolio. There is a limit on how much to hold a particular stock.
Ark Invest bought 52.52K Tesla's share worth $15.15M
https://www.moomoo.com/community/feed/113444265394582?share_code=01zfkB
Sor Shi Dll OP ZnWC : I updated my post, TSLA bought about 1 B on Nov 6.